Group 1 - The Shanghai Stock Exchange will hold its 29th listing review committee meeting on August 7, 2025, to review the initial public offering (IPO) of Suzhou Fengbei Biotechnology Co., Ltd. [1] - Fengbei Biotechnology plans to issue no more than 35.90 million shares, with the public offering accounting for at least 25% of the total share capital after the issuance [1] - The company aims to raise 750 million yuan, which will be used for the construction of projects including an annual production of 300,000 tons of oleic acid methyl ester, 10,000 tons of industrial-grade mixed oil, 50,000 tons of agricultural microbial agents, 10,000 tons of compound microbial fertilizers, and by-products such as 50,000 tons of biodiesel and 8,200 tons of glycerol [1] Group 2 - The lead underwriter for this issuance is Guotai Junan Securities Co., Ltd., with representatives Hu Bo and Jin Xiang overseeing the process [1]
丰倍生物8月7日上交所主板首发上会 拟募资7.5亿元
Zhong Guo Jing Ji Wang·2025-07-31 13:05